Start date: 01 July 2022
End date: 30 June 2027
The HERVCOV project aims to analyze the role of human endogenous retroviruses (HERVs), known for their high pro-inflammatory potential, in the immunopathogenesis of COVID-19 and its long-term complications and to identify and evaluate a set of biomarkers which will be important for the diagnosis, prognosis and follow-up of patients and their prioritization for targeted therapy;
The project has started in summer 2022, putting together 8 partners with complementary experience from 5 European countries. This study has already produced first evidence for the induction of a specific protein during COVID-19 disease.
The data obtained from the project may guide predictive and personalized medicine and could thus contribute to developing, strengthening or improving EU policy priorities in the treatment of COVID-19 and its complications.
(Press release)
Scientific coordinator of the project: Branka Horvat